摘要
目的:观察田黄方对高尿酸血症肾病(HN)小鼠肾损伤的保护作用,并通过网络药理学探讨其可能的作用机制。方法:将所有小鼠随机分为5组,正常组、模型组、非布司他组、田黄方低、高剂量组。正常组小鼠每日灌胃0.5%羧甲基纤维素钠(CMC-Na),其余组小鼠灌胃500 mg·kg^(-1)次黄嘌呤和腹腔注射200 mg·kg^(-1)氧嗪酸钾诱导HN模型,非布司他组小鼠每日灌胃5 mg·kg^(-1)非布司他,田黄方组小鼠每日灌胃60 mg·kg^(-1)和120 mg·kg^(-1)田黄方,连续给药3周。检测小鼠血清尿酸、肌酐、尿素氮水平和24 h尿蛋白含量;采用苏木素-伊红(HE)染色和过碘酸雪夫(PAS)染色观察肾脏损伤程度,采用天狼猩红染色观察肾脏纤维化情况;通过蛋白免疫印迹法(Western blot)、网络药理学及分子对接研究田黄方在HN小鼠中的作用及其分子机制。结果:生化结果提示,与模型组比较,田黄方低剂量组BUN和24 h尿蛋白水平明显降低(P<0.05),SUA、SCr水平显著降低(P<0.01),田黄方高剂量组,SUA、BUN、SCr和24 h尿蛋白水平显著降低(P<0.01);病理染色结果表明田黄方各剂量组对肾脏损伤和间质纤维化有不同程度改善作用(P<0.05);Western blot结果表明田黄方高剂量组能够使NOD样受体热蛋白结构域相关蛋白3(NLRP3)炎性小体、白细胞介素-1β(IL-1β)、纤维黏连蛋白(FN)、及尿酸转运蛋白1(URAT1)、磷酸化p65(p-p65)和磷酸化核转录因子(NF)-κB抑制蛋白α(p-IκBα)的表达降低到正常水平(P<0.01),而田黄方低剂量组不影响HN小鼠IL-1β、URAT1和p-IκBα的蛋白表达。结论:田黄方通过抑制NF-κB和NLRP3炎性小体激活改善肾脏炎症和纤维化减轻HN。
Objective:To observe the protective effect and mechanism of Tianhuang formula(THF)against renal injury in hyperuricemia nephropathy(HN)mice through network pharmacology.Method:All mice were randomly divided into a normal group,a model group,a febuxostat group(5 mg·kg^(-1)),a low-dose THF group(L-THF,60 mg·kg^(-1)),and a high-dose THF group(H-THF,120 mg·kg^(-1)).The mice in the normal group were treated with 0.5%sodium carboxymethylcellulose(CMC-Na)by gavage daily.The HN model was induced by oral administration of 500 mg·kg^(-1) hypoxanthine and intraperitoneal injection of 200 mg·kg^(-1) oteracil potassium in mice except for those in the blank group.The mice in the groups with drug intervention were treated with corresponding drugs by gavage for three weeks.The levels of serum uric acid,creatinine,urea nitrogen,and 24-h albuminuria were measured.The renal injury was observed by hematoxylin-eosin(HE)staining and PAS staining,and renal fibrosis was observed by Sirius red staining.The effects and molecular mechanism of THF in HN mice were analyzed by Western blot,network pharmacology,and molecular docking.Result:Biochemical results indicated that compared with model group,BUN and 24 h urinary protein levels were significantly decreased in L-THF group(P<0.05),SUA and SCr levels were significantly decreased(P<0.01),and SUA,BUN,SCr and 24 h urinary protein levels in H-THF group were significantly decreased(P<0.01).The results of pathological staining showed that the kidney injury and interstitial fibrosis were improved in different doses of THF groups(P<0.05).Western blot results showed that the Nod-like receptor heat protein domain associated protein 3(NLRP3)inflammatorome,interleukin-1β(IL-1β),fibronectin(FN),uric acid transporter 1(URAT1),phosphorylated p65(p-p65)and phosphorylated nuclear transcription factor(NF)-κB were inhibited in the HTHF group The expression of protein-producingα(p-IκBα)was reduced to the normal level(P<0.01),but the expression of IL-1β,URAT1 and p-IκBαin HN mice was not affected in the L-THF group.Conclusion:THF ameliorates renal inflammation and fibrosis by inhibiting the activation of NF-κB and NLRP3 inflammasomes to alleviate HN.
作者
莫菊鲜
吴铠礽
李明慧
陈哲
兰天
肖炜
郭姣
MO Juxian;WU Kaireng;LI Minghui;CHEN Zhe;LAN Tian;XIAO Wei;GUO Jiao(Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine,Key Laboratory of Glucolipid Metabolic Disorder,Ministry of Education,Guangdong Traditional Chinese Medicine(TCM)Key Laboratory for Metabolic Diseases,Institute of Chinese Medicine,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of TCM,Guangdong Pharmaceutical University,Guangzhou 510006,China)
出处
《中国实验方剂学杂志》
CAS
CSCD
北大核心
2023年第11期72-81,共10页
Chinese Journal of Experimental Traditional Medical Formulae
基金
国家自然科学基金项目(81830113,81870420)
广东省基础与应用基础研究重大项目(2019B030302005)
国家重点研发计划中医药现代化研究项目(2018YFC1704200)。
关键词
田黄方
高尿酸血症肾病
网络药理学
肾脏损伤
炎症
纤维化
Tianhuang formula
hyperuricemia nephropathy
network pharmacology
renal injury
inflammation
fibrosis
